AFP and liver cancer: Some liver cancer staging systems, such as the Biomarker Combined Japan Integrated Staging (bm-JIS) and the CLIP score, also utilize serum AFP levels (8, 26), whereas AFP levels ≤400 ng/mL are included in the Hangzhou criteria as a patient selection criterion before liver transplantation (27).